# Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery

> **NCT03424239** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 6 (actual)

## Conditions studied

- Bariatric Surgery Candidate

## Interventions

- **DRUG:** Zoledronic Acid
- **DIETARY_SUPPLEMENT:** Calcium citrate + vitamin D
- **DIETARY_SUPPLEMENT:** Vitamin D3

## Key facts

- **NCT ID:** NCT03424239
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03424239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03424239, "Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03424239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*